Biosimilars: How Can Payers Get Long-Term Savings?

PharmacoEconomics - United Kingdom
doi 10.1007/s40273-015-0380-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Will U.S. Payers Champion Biosimilars?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

How High Can Patients Get on CBD?

Epilepsy Currents
Neurology
2019English

How Can Biosimilars Change the Trajectory of Breast Cancer Therapy?

Expert Review of Anticancer Therapy
OncologyPharmacology
2020English

Cigarette Smoking : How Much Worse Can It Get?

Circulation
Cardiovascular MedicinePhysiologyCardiology
2000English

How Far Can the Long Term Perspective for Defence 2030 Sees?

Vojenské rozhledy
2015English

Long-Term Portfolio Choice Given Uncertain Personal Savings

SSRN Electronic Journal
2002English

Biosimilars: Ensuring Safety in the Search for Savings

Prescriber
Pharmacology
2017English

Bottomless Determination: How Yablo Can Get Proportionality From Gunk

Analysis
Philosophy
2011English

How Can Associations Get More Biomeds to Attend Meetings?

Biomedical Instrumentation and Technology
Computer NetworksBiomedical EngineeringCommunications
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy